With a focus on artificial intelligence (AI) sleep data analysis, HoneyNaps, a Seoul, South Korea-based startup, has secured $11.6 million in investment.
Investors
- QUAD Investment Management
- Hi Investment Partners
- Korea Industrial Bank
Use of funds
The business plans to utilize the money to increase both its development and operational activities.
Since its founding in July 2015, HoneyNaps has raised around $16.2 million.
About HoneyNaps
The “Sleep-Tech” startup HoneyNaps received FDA clearance in 2023 for their AI-powered SOMNUM sleep diagnostic software. This algorithm uses its own AI model to detect diseases in less than five minutes by analyzing biosignal data collected during sleep. Any medical or healthcare industry may include this AI diagnostic software utilizing real-time large-scale bio signals.
